Altimmune Inc (ALT) stock news · rev $41.0K
Altimmune Inc (ALT) is a biotechnology company listed on US.
This ALT news page leads with what Altimmune Inc filed — not a scraped headline mill.
No cached 8-K sentence for ALT yet. We will not pad this page with generic market recap.
Latest reported ALT revenue for 2025-12-31 was $41.0K. Net income was -$88.1M. Revenue was up 105.0% from 2024-12-31 to 2025-12-31. ALT currently screens at market cap $527.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ALT stock page; for the tape open the quote page.
ALT stock news FAQ
What are ALT's latest revenue and net income?
Latest cached Altimmune Inc (ALT) revenue for Dec 31, 2025 was $41.0K. Net income was -$88.1M. Statements: https://lician.com/financials/alt
How did ALT revenue change from the prior cached period?
Cached Altimmune Inc (ALT) revenue was up 105.0% from $20.0K (Dec 31, 2024) to $41.0K (Dec 31, 2025). Statements: https://lician.com/financials/alt
What is ALT's market cap?
Altimmune Inc (ALT) market cap is $527.0M on the latest cached fundamentals snapshot.
What kind of company is ALT?
Altimmune Inc (ALT) is a biotechnology company listed on US.
Where is ALT stock news listed?
Cached stock news for Altimmune Inc (ALT) is listed at https://lician.com/news/alt. Filings: https://lician.com/sec/alt
Not investment advice.